[Skip to Content]
Eliminating cancer, preserving the bladder, with guest Joseph Jacob, MD, on Upstate's The Informed Patient podcast

New bladder cancer treatment would keep the organ intact

A new, targeted therapy might be an option for some patients with high-risk bladder cancers who would rather not have their bladders removed. Joseph Jacob, MD, tells about promising clinical trials of TAR-200 that involve patients from Upstate Medical University. He’s an associate professor of urology at Upstate, specializing in urologic cancers.